Common Contracts
6 similar Nonstatutory Stock Option Agreement contracts by Syros Pharmaceuticals, Inc., Editas Medicine, Inc., Visterra, Inc.
SYROS PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT Granted under 2022 Inducement Stock Incentive PlanNonstatutory Stock Option Agreement • March 15th, 2022 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
VISTERRA, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • January 17th, 2017 • Visterra, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
SYROS PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • June 3rd, 2016 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
SYROS PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • February 5th, 2016 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
EDITAS MEDICINE, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • January 4th, 2016 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
EDITAS MEDICINE, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • December 15th, 2015 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
